[Silent coronary artery disease in diabetic patients. New guidelines]

P Valensi1

  • 1Hôpital Jean Verdier, AP-HP, Université Paris-Nord, Avenue du 14 Juillet, 93140 Bondy, France. paul.valensi@jvr.ap-hop-paris.fr

Insights

Diabetic patients with silent myocardial ischemia face higher cardiac event risks. Early detection through screening and diagnostic tests is crucial for timely intervention and improved prognosis.

Area of Science:

  • Cardiology
  • Diabetology
  • Internal Medicine

Context:

  • Coronary artery disease (CAD) presents atypically in diabetic individuals.
  • Silent myocardial ischemia (SMI) affects 20-35% of diabetics with risk factors.
  • SMI in diabetics portends a poorer prognosis, especially with coronary stenosis.

Purpose:

  • To outline screening guidelines for SMI in at-risk diabetic populations.
  • To detail diagnostic modalities for detecting SMI in diabetics.
  • To establish criteria for coronary angiography in diabetic patients with SMI.

Summary:

  • French guidelines recommend SMI screening for specific diabetic subgroups based on risk factors and complications.
  • Recommended screening includes exercise tests, myocardial scintigraphy, or stress echocardiography.
  • Coronary angiography is advised for SMI patients eligible for revascularization.

Impact:

  • Facilitates early identification of high-risk diabetic patients with SMI.
  • Guides clinical decision-making for further diagnostic workup and treatment.
  • Aims to reduce cardiac mortality and morbidity in the diabetic population.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...